FSD Pharma Announces Holdings in Cannara Biotech Inc.
January 11, 2019
Canada NewsWire TORONTO, Jan. 11, 2019 TORONTO, Jan. 11, 2019 /CNW/ – FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD... Read more
Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018
Uncategorized January 8, 2019
Ryan Allway January 8th, 2019 Uncategorized The O’Cannabiz Conference and Expo in Vancouver, Canada last month featured hundreds of cannabis companies from around the world this year—and CFN Media was there to film exclusive interviews with many of the leaders in the space. Lexaria Biosciences Inc. (CSE: LXX) (OTCQX:... Read more
High Hampton Holdings Corp. Reports the Fourth Quarter 2018 Financial Results and Provides an Operational and Corporate Update
December 28, 2018
TORONTO, Dec. 28, 2018 CSE: HCOTC: HHPHFFSE: 0HCN TORONTO, Dec. 28, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”) today announced that it has filed its Consolidated Audited Financial Statements for the year ended August 31, 2018. The Consolidated Financial Statements... Read more
Gabriella’s Kitchen Adding Seasoned Executives to Its Board
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be... Read more
Ryan Allway December 20th, 2018 Uncategorized Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the... Read more
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for... Read more
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
December 20, 2018
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
High Hampton’s Mojave Jane Announces Start Of Production In California January 2019
December 19, 2018
“While Mojave Jane’s production delivers revenue and cash flow to the Company, it also means realizing the advantages of integrating with High Hampton’s complete portfolio”, commented Gary Latham, High Hampton’s CEO. “That is where the real long term value of this company will be realized.” About Mojave Jane LLC.... Read more
Creso Pharma Brings Together Cannabis Experts Across Several Verticals
December 18, 2018
Ryan Allway December 18th, 2018 Exclusive, Top News The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage... Read more
Wayland Announces Significant Supply Agreement with RavenQuest BioMed
December 18, 2018
TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in... Read more
